CompletedNot Applicable

Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye

France80 participantsStarted 2019-11-14

Plain-language summary

LacryDiag is a new Conformity European (CE) marked diagnostic imaging device devoted to the analysis of the ocular surface. It is an "all in one" device that provides 4 data: non-invasive break-up time (Non-Invasive Break-Up-Time (NIBUT) without fluorescein eye drop); height of the Tear Meniscus (TM); an infrared image of the meibomian glands; a picture of the lacrimal film by interferometry. it's performance will be compare between in diagnosing dry eye syndrome with the standard clinical evaluation, in 80 patients suffering from dry eye diseases and followed at the consultation of the Ophthalmology department of the University Hospital of Saint-Etienne.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Affiliates or beneficiaries of social security scheme * With Dry eye of any cause, diagnosed with conventional means * Signed informed consent Exclusion Criteria: * Major blepharospasm * Serious illness preventing participation according to investigator * Allergy to fluorescein * Pregnant or / and breastfeeding women * Under guardianship, curatorship or safeguard of justice * Unable to express their consent * Person in emergency situation

What they're measuring

Break-Up-Time (BUT)

Timeframe: Day: 1

Trial details

NCT IDNCT04093037

SponsorCentre Hospitalier Universitaire de Saint Etienne

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-08-27

View on ClinicalTrials.gov More Dry Eye trials